Integrating Emerging Targeted Therapies Into AML Treatment Strategies

Slideset - In this downloadable slideset, Roland B. Walter, MD, PhD, MS, examines FLT3, IDH1, and BCL2 inhibitors as well as other promising investigational treatments in clinical trial that may provide therapeutic advances for the management of patients with acute myeloid leukemia.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research